AbbVie After Purchase Apogee? Is It a Buy Now for Investors
AbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Knowing which debts to pay off first is crucial for effective financial management. Explore the best approaches to prioritize your repayments.
25,509 articlesAbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
London moves away from wallet limits toward a single market cap on sterling stablecoins, signaling a friendlier frame...
Ouster and Aeva powered higher in a Tuesday session, as investors priced in a new wave of demand for physical AI lida...
May data show 7.6 million job openings, topping forecasts and signaling stabilization in the labor market. Thursday's...
Telecom stocks face a yield squeeze as SpaceX's Starlink tests the bounds of traditional connectivity. This report we...
Tightening UK election funding rules are set to change how crypto wealth can fund political campaigns. This could alt...
On July 1, Meta Platforms lit up the market with a 9% jump that pushed the stock toward $612.91. The move followed re...
A circuit board problem just delayed Nvidia’s next AI system to 2028, highlighting how hardware assembly bottlenecks ...
Starboard Value’s effort at Dynatrace tests whether the observability software maker can turn around on its own or be...
Pricing swings often follow earnings news. This guide breaks down whether to buy NOW stock before July 22, with pract...
Jim Cramer argues Meta's AI model shift delivered a roughly $100 per share move, illustrating why big tech remains ha...
When a local emergency provider faces a court case over funds, it isn’t just a headline—it can affect budgets, bills,...